NHI SVP gets 3,458 restricted shares, 411 withheld

National Health Investors Inc. reported that SVP and Chief Accounting Officer David L. Travis received a grant of 3,458 shares of common stock as restricted stock on March 3, 2026.

Accepted by SEC EDGAR 03/05/2026 - 04:54 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

National Health Investors Inc. reported that SVP and Chief Accounting Officer David L. Travis received a grant of 3,458 shares of common stock as restricted stock on March 3, 2026. According to the filing, this restricted stock vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to his continued service through each vesting date.

The company also withheld 411 shares of common stock at a price of $86.75 per share to cover tax withholding obligations related to restricted stock vesting on March 3, 2026. After these transactions, Travis directly owned 40,847 shares of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Travis David L

Role SVP/Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,458	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	411	$86.75	$36K

Holdings After Transaction: Common Stock — 40,847 shares (Direct)

Holdings Before and After: Common Stock, 37,800 to 40,847 shares (Direct)

Footnotes (2)

1. F1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.
2. F2. Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 3, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did NHI SVP David L. Travis report on this Form 4?

NHI SVP and Chief Accounting Officer David L. Travis reported a grant of 3,458 shares of restricted common stock and a withholding of 411 shares to satisfy tax obligations related to vesting on March 3, 2026.

How does the restricted stock granted to NHI’s David L. Travis vest?

The 3,458 restricted shares granted to David L. Travis vest in three equal annual installments on each anniversary of the March 3, 2026 grant date, beginning March 3, 2027, conditioned on continued service through each vesting date.

Why were 411 NHI shares disposed of in David L. Travis’s Form 4?

The 411 shares reported as a disposition were withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 3, 2026, rather than an open-market sale.

What is David L. Travis’s NHI common stock ownership after these transactions?

Following the reported grant and tax-withholding disposition, David L. Travis directly owned 40,847 shares of National Health Investors Inc. common stock, as stated in the Form 4 beneficial ownership table after the transactions on March 3, 2026.

What role does David L. Travis hold at National Health Investors Inc. (NHI)?

David L. Travis serves as Senior Vice President and Chief Accounting Officer of National Health Investors Inc., as identified in the Form 4, and is the reporting person for the restricted stock grant and related tax-withholding share disposition.

How is the tax withholding transaction characterized in NHI’s Form 4 for David L. Travis?

The tax withholding is coded as “F”, described as payment of tax liability by delivering securities. It is labeled a tax-withholding disposition of 411 shares of common stock at $86.75 per share, held directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Travis David L

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP/Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		3,458(1)	A	$0	41,258	D
Common Stock	03/03/2026		F		411(2)	D	$86.75	40,847	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock that vests in three equal annual installments on each anniversary of the grant date beginning March 3, 2027, subject to the reporting person's continued service through each vesting date.

2. Represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 3, 2026.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.